This is a Validated Antibody Database (VAD) review about human KRT19, based on 235 published articles (read how Labome selects the articles), using KRT19 antibody in all methods. It is aimed to help Labome visitors find the most suited KRT19 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KRT19 synonym: CK19; K19; K1CS

Abcam
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 4f
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 4f). iScience (2022) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 1b
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1b). Nat Commun (2022) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1d
Abcam KRT19 antibody (abcam, ab52625) was used in immunohistochemistry on mouse samples at 1:200 (fig 1d). Nat Commun (2022) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; human; 1:500; fig 1c, 1d
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry on human samples at 1:500 (fig 1c, 1d). elife (2022) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 1s1a
  • immunohistochemistry; human; 1:500; fig 1c, 1d
Abcam KRT19 antibody (Abcam, ab9221) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 1s1a) and in immunohistochemistry on human samples at 1:500 (fig 1c, 1d). elife (2022) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 2e
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 2e). Burns Trauma (2022) ncbi
mouse monoclonal (A53-B)
  • immunohistochemistry; human; loading ...; fig 3
Abcam KRT19 antibody (Abcam, ab194399) was used in immunohistochemistry on human samples (fig 3). Front Med (Lausanne) (2021) ncbi
mouse monoclonal (A53-B/A2)
  • immunocytochemistry; pigs ; loading ...; fig 1a
Abcam KRT19 antibody (Abcam, ab7754) was used in immunocytochemistry on pigs samples (fig 1a). Sci Rep (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
Abcam KRT19 antibody (ABCAM, ab52625) was used in immunohistochemistry - paraffin section on human samples (fig s1). Adv Sci (Weinh) (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; mouse; 1:200; fig s1
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry on mouse samples at 1:200 (fig s1). Arch Toxicol (2021) ncbi
domestic rabbit monoclonal (EPR1579Y)
  • immunocytochemistry; human; loading ...; fig 6j
Abcam KRT19 antibody (Abcam, ab76539) was used in immunocytochemistry on human samples (fig 6j). elife (2021) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 7c
Abcam KRT19 antibody (Abcam, ab9221) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 7c). Cell Stem Cell (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1d
Abcam KRT19 antibody (Epitomics, AC-0073) was used in immunohistochemistry on mouse samples at 1:200 (fig 1d). Commun Biol (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s12b
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s12b) and in immunocytochemistry on human samples at 1:100 (fig 1c). Science (2021) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s12b
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Abcam KRT19 antibody (Abcam, ab7754) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s12b) and in immunocytochemistry on human samples at 1:100 (fig 1c). Science (2021) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 3a
Abcam KRT19 antibody (Abcam, ab133496) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3a). Eur J Immunol (2021) ncbi
domestic rabbit monoclonal
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1e
Abcam KRT19 antibody (Abcam, ab192980) was used in immunohistochemistry - frozen section on mouse samples (fig 1e). Cell Mol Gastroenterol Hepatol (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1f
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry on mouse samples at 1:200 (fig 1f). Life Sci Alliance (2021) ncbi
domestic rabbit monoclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
Abcam KRT19 antibody (Abcam, ab203445) was used in immunohistochemistry - paraffin section on human samples (fig 1). Proc Natl Acad Sci U S A (2020) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; mouse; fig 7d
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on mouse samples (fig 7d). Cancer Sci (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2c
  • western blot; human; 1:5000; loading ...; fig 2a
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2c
  • western blot; mouse; 1:5000; loading ...; fig s2a
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2c), in western blot on human samples at 1:5000 (fig 2a), in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2c) and in western blot on mouse samples at 1:5000 (fig s2a). MBio (2020) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 5b
Abcam KRT19 antibody (Abcam, ab133496) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5b). elife (2020) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunocytochemistry; mouse; 1:200; loading ...; fig s3f
  • immunohistochemistry; mouse; 1:200; loading ...; fig s10c
Abcam KRT19 antibody (Abcam, ab133496) was used in immunocytochemistry on mouse samples at 1:200 (fig s3f) and in immunohistochemistry on mouse samples at 1:200 (fig s10c). Hepatology (2021) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig s2b
Abcam KRT19 antibody (Abcam, Ab52625) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s2b). Cancer Cell (2020) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 3a
Abcam KRT19 antibody (Abcam, ab133496) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3a). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; human; 1:200; loading ...; fig 5e
Abcam KRT19 antibody (abcam, ab52625) was used in immunohistochemistry on human samples at 1:200 (fig 5e). Nat Commun (2019) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:250; loading ...; fig 2e
Abcam KRT19 antibody (Abcam, ab133496) was used in immunohistochemistry on mouse samples at 1:250 (fig 2e). Carcinogenesis (2019) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunocytochemistry; human; 1:200; loading ...; fig 2c
Abcam KRT19 antibody (Abcam, ab52625) was used in immunocytochemistry on human samples at 1:200 (fig 2c). Stem Cell Res Ther (2019) ncbi
domestic rabbit monoclonal (EP1580Y)
  • western blot; human; loading ...; fig s4b
Abcam KRT19 antibody (Abcam, ab52625) was used in western blot on human samples (fig s4b). Cell (2019) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:800; loading ...; fig s4f
Abcam KRT19 antibody (Abcam, EPNCIR127B) was used in immunohistochemistry on mouse samples at 1:800 (fig s4f). Nature (2019) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunocytochemistry; mouse; 1:100; loading ...; fig 3b
  • western blot; mouse; 1:500; loading ...; fig 2b
Abcam KRT19 antibody (Abcam, ab52625) was used in immunocytochemistry on mouse samples at 1:100 (fig 3b) and in western blot on mouse samples at 1:500 (fig 2b). Int J Mol Sci (2019) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s3a
Abcam KRT19 antibody (Abcam, EPNCIR127B) was used in immunohistochemistry - frozen section on mouse samples (fig s3a). Nat Immunol (2019) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - frozen section; human; loading ...; fig 1c
Abcam KRT19 antibody (Abcam, A53-B/A2) was used in immunohistochemistry - frozen section on human samples (fig 1c). Cancer Res (2018) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1d
Abcam KRT19 antibody (Abcam, EP1580Y) was used in immunohistochemistry - frozen section on mouse samples (fig 1d). Science (2018) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry; mouse; 1:400; fig 4f
Abcam KRT19 antibody (Abcam, 52625) was used in immunohistochemistry on mouse samples at 1:400 (fig 4f). Nature (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; rat; loading ...; fig 94
In order to outline the protocols for antibodies used for immunohistochemical studies, Abcam KRT19 antibody (Abcam, ab15463) was used in immunohistochemistry on rat samples (fig 94). J Toxicol Pathol (2017) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s2a
In order to generate and characterize rat-sized pancreata composed of mouse-derived pluripotent stem cells, Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on mouse samples (fig s2a). Nature (2017) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - paraffin section; human; loading ...; fig 3a
Abcam KRT19 antibody (Abcam, A53-B/A2) was used in immunohistochemistry - paraffin section on human samples (fig 3a). Lab Invest (2017) ncbi
mouse monoclonal (BA16)
  • immunohistochemistry - frozen section; human; 1:50; loading ...; fig 4
  • immunocytochemistry; human; 1:25; loading ...; fig 2
In order to discuss estrogen receptor regulation and function in normal breast and breast cancer, Abcam KRT19 antibody (Abcam, BA16) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 4) and in immunocytochemistry on human samples at 1:25 (fig 2). Oncotarget (2017) ncbi
mouse monoclonal (A53-B/A2)
  • immunocytochemistry; human; fig s1e
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., Abcam KRT19 antibody (Abcam, A53-B/A2) was used in immunocytochemistry on human samples (fig s1e). Nature (2017) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry; human; 1:50; loading ...; fig 1b
In order to discuss changes in the expression of mitochondrial ribosomal proteins in cancer, Abcam KRT19 antibody (Abcam, ab7754) was used in immunohistochemistry on human samples at 1:50 (fig 1b). BMC Cancer (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:40; loading ...; fig 2e
In order to examine the liver regeneration process after physical partial hepatectomy, Abcam KRT19 antibody (Abcam, ab15463) was used in immunohistochemistry - frozen section on mouse samples at 1:40 (fig 2e). Lab Invest (2016) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:100; fig 10a
Abcam KRT19 antibody (Abcam, ab133496) was used in immunohistochemistry on mouse samples at 1:100 (fig 10a). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; fig 2
Abcam KRT19 antibody (Abcam, ab15463) was used in immunohistochemistry on mouse samples at 1:100 (fig 2). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
  • western blot; human; 1:500; fig 5
Abcam KRT19 antibody (Abcam, ab53119) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2) and in western blot on human samples at 1:500 (fig 5). Int J Mol Med (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s2
In order to characterize attenuation of liver fibrosis by direct reprogramming of hepatic myofibroblasts into hepatocytes in vivo, Abcam KRT19 antibody (Abcam, 15463) was used in immunohistochemistry - paraffin section on mouse samples (fig s2). Cell Stem Cell (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:800; fig 4
In order to describe protocols to generate specific pancreatic lineages from hPSCs, Abcam KRT19 antibody (Abcam, ab15463) was used in immunohistochemistry - paraffin section on human samples at 1:800 (fig 4). Methods (2016) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; 1:400
In order to analyze a model for ductal pancreatic cancer and drug screening, Abcam KRT19 antibody (Abcam, ab9221) was used in immunohistochemistry - paraffin section on human samples at 1:400. Nat Med (2015) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 3
Abcam KRT19 antibody (Abcam, Ab133496) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3). J Cell Mol Med (2015) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry - paraffin section; mouse; 1:5000; fig 4
In order to study inhibition of initiation of pancreatic ductal adenocarcinoma due to acinar differentiation determinant PTF1A, Abcam KRT19 antibody (Abcam, AB133496) was used in immunohistochemistry - paraffin section on mouse samples at 1:5000 (fig 4). elife (2015) ncbi
domestic rabbit monoclonal (EP1580Y)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4C
Abcam KRT19 antibody (Abcam, ab52625) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4C). Sci Rep (2015) ncbi
domestic rabbit monoclonal (EPNCIR127B)
  • immunohistochemistry; mouse; 1:200
Abcam KRT19 antibody (abcam, ab133496) was used in immunohistochemistry on mouse samples at 1:200. PLoS ONE (2015) ncbi
mouse monoclonal (A53-B/A2)
  • immunocytochemistry; human; 1:25
  • immunohistochemistry; human; 1:25
In order to investigate the role of CEACAM6 in luminal, HER2-enriched, and basal-like breast cancers, Abcam KRT19 antibody (Abcam, A53-B/A2) was used in immunocytochemistry on human samples at 1:25 and in immunohistochemistry on human samples at 1:25. Am J Pathol (2014) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human
In order to define the cellular phenotype of maternal microchimeric cells in control and type 1 diabetes pancreas, Abcam KRT19 antibody (Abcam, Ab9221) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (EPR1579Y)
  • immunohistochemistry - paraffin section; human; fig 2
Abcam KRT19 antibody (Abcam, ab76539) was used in immunohistochemistry - paraffin section on human samples (fig 2). Cell Death Dis (2013) ncbi
domestic rabbit monoclonal (EPR1579Y)
  • immunocytochemistry; human
Abcam KRT19 antibody (Abcam, ab76539) was used in immunocytochemistry on human samples . Stem Cells Dev (2014) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry - frozen section; mouse
Abcam KRT19 antibody (Abcam, ab7754) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry - frozen section on mouse samples . PLoS ONE (2013) ncbi
Invitrogen
mouse monoclonal (BA17)
  • immunohistochemistry - free floating section; mouse; 1:250; loading ...; fig 4s1
Invitrogen KRT19 antibody (Invitrogen, 14-9898-82) was used in immunohistochemistry - free floating section on mouse samples at 1:250 (fig 4s1). elife (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 6b
Invitrogen KRT19 antibody (eBioscience, 53-9003-82) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6b). Commun Biol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2, 4a, 4b
Invitrogen KRT19 antibody (InVitrogen, MA5-13156) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2, 4a, 4b). Mol Oncol (2022) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen KRT19 antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry; human; fig 6c
Invitrogen KRT19 antibody (Thermo Fisher, MA5-12,663) was used in immunohistochemistry on human samples (fig 6c). Sci Rep (2021) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human; loading ...
Invitrogen KRT19 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples . Nat Commun (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen KRT19 antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen KRT19 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen KRT19 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen KRT19 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (BA17)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3e
Invitrogen KRT19 antibody (eBioscience, 14-9898-82) was used in immunohistochemistry - paraffin section on mouse samples (fig 3e). Cancer Res (2018) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen KRT19 antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen KRT19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • reverse phase protein lysate microarray; human; loading ...; fig 7a
In order to characterize the molecular identity of uterine carcinosarcomas., Invitrogen KRT19 antibody (Lab Vision, MS-201-P1ABX) was used in reverse phase protein lysate microarray on human samples (fig 7a). Cancer Cell (2017) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunocytochemistry; human; 1:1000; loading ...; fig 1c
  • western blot; human; 1:1000; loading ...; fig 2c
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., Invitrogen KRT19 antibody (Thermo Scientific, MS-198) was used in immunocytochemistry on human samples at 1:1000 (fig 1c) and in western blot on human samples at 1:1000 (fig 2c). Nature (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen KRT19 antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry - paraffin section; human; loading ...; fig 1c
In order to assess the use of CD56, HBME-1, cytokeratin 19 expression in papillary thyroid carcinoma and thyroid nodular lesions for differential diagnosis, Invitrogen KRT19 antibody (Thermo Fisher, A53-B/A2.26) was used in immunohistochemistry - paraffin section on human samples (fig 1c). J Res Med Sci (2016) ncbi
mouse monoclonal (RCK108)
  • immunocytochemistry; human; loading ...; fig 2f
  • western blot; human; loading ...; fig 2e
In order to study factors that influence the localization of casein kinase 1, Invitrogen KRT19 antibody (Thermo Fisher, RCK108) was used in immunocytochemistry on human samples (fig 2f) and in western blot on human samples (fig 2e). Sci Rep (2016) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen KRT19 antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen KRT19 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen KRT19 antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry; human; 1:100
In order to characterize a case where diagnosis of thyroid paraganglioma occurred by fine-needle aspiration biopsy and histopathological findings, Invitrogen KRT19 antibody (Thermo Scientific, A53-B/A2.26) was used in immunohistochemistry on human samples at 1:100. Diagn Cytopathol (2016) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry - paraffin section; human; 1:2000; fig 4
  • western blot; human; fig 4
In order to analyze high-grade serous epithelial ovarian cancer cell lines that show sporadic and hereditary disease and the molecular diversity, Invitrogen KRT19 antibody (Thermo Fisher Scientific, MS198-P) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 4) and in western blot on human samples (fig 4). Genes Cancer (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen KRT19 antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen KRT19 antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen KRT19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen KRT19 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry - paraffin section; human; fig s1
In order to research by use of a multi-staining immunofluorescence co-localization assay to study potential cross-talk beteween classical and alternative NF-kappaB pathways in prostate cancer tissues, Invitrogen KRT19 antibody (Thermo Scientific Lab Vision, ms-198-P0) was used in immunohistochemistry - paraffin section on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry - paraffin section; human; fig 1c
In order to investigate using additional markers for core needle biopsy of thyroid nodules, Invitrogen KRT19 antibody (Thermo Fisher Scientific, A53-B) was used in immunohistochemistry - paraffin section on human samples (fig 1c). Endocrine (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen KRT19 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry - paraffin section; human; fig 7
In order to study the increase in stromal collagen and immune cells within the mammary epithelium shown as high mammographic density, Invitrogen KRT19 antibody (Pierce, A53-B/A2.26) was used in immunohistochemistry - paraffin section on human samples (fig 7). Breast Cancer Res (2015) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry - paraffin section; human; 1:50
In order to study the prognostic effect of Keratin 19 expression on survival of patients with human hepatocellular carcinoma, Invitrogen KRT19 antibody (Thermo Scientific, A53-B/A.2.26) was used in immunohistochemistry - paraffin section on human samples at 1:50. Eur J Gastroenterol Hepatol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen KRT19 antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen KRT19 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen KRT19 antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen KRT19 antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunocytochemistry; human; 1:200; fig 1
In order to study and identify critical cell lineage-dependent transduction bias to model breast cancer properly, Invitrogen KRT19 antibody (Neomarkers/Thermo, A53-B/A2.26) was used in immunocytochemistry on human samples at 1:200 (fig 1). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen KRT19 antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry; human
In order to assess the properties of well differentiated thyroid tumors by histomorphological and immunohistochemical analysis, Invitrogen KRT19 antibody (Lab vision, A53-B/A2.26) was used in immunohistochemistry on human samples . J Egypt Natl Canc Inst (2015) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathologically features of two cases of kidney mucinous tubular and spindle cell carcinoma, Invitrogen KRT19 antibody (THERMO, A53-B/A2.26) was used in immunohistochemistry - paraffin section on human samples . Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen KRT19 antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (BA17)
  • immunohistochemistry - paraffin section; black ferret; 1:1; fig 6
In order to use of ferrets to characterize immunohistochemical and histochemical levels of chordoma, Invitrogen KRT19 antibody (Thermo Fisher Scientific, BA17) was used in immunohistochemistry - paraffin section on black ferret samples at 1:1 (fig 6). J Vet Med Sci (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT19 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT19 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen KRT19 antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen KRT19 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry; human; ready-to-use
In order to describe a tumor from a patient with oncocytic cystadenoma, Invitrogen KRT19 antibody (Thermo Scientific, AE1) was used in immunohistochemistry on human samples at ready-to-use. Medicine (Baltimore) (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen KRT19 antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen KRT19 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT19 antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen KRT19 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; human; fig 1
In order to establish an in vitro system to study three-dimensional corneal differentiation, Invitrogen KRT19 antibody (Thermo Fisher Scientific, MS1902P0) was used in immunohistochemistry on human samples (fig 1). Nature (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen KRT19 antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen KRT19 antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen KRT19 antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen KRT19 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen KRT19 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen KRT19 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen KRT19 antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunocytochemistry; human
In order to develop a telomerase-imortalized human primary gingival epithelial cell line, Invitrogen KRT19 antibody (Thermo Scientific, Ks19.1) was used in immunocytochemistry on human samples . J Periodontal Res (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen KRT19 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen KRT19 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • western blot; human; fig 4
In order to characterise novel sinonasal undifferentiated carcinoma cell lines, Invitrogen KRT19 antibody (Thermo Fisher, A53-B/A2.26) was used in western blot on human samples (fig 4). Clin Cancer Res (2012) ncbi
mouse monoclonal (A53-B/A2.26 (Ks19.1))
  • immunohistochemistry; human; fig 1
In order to determine the role of secretory products of fibrous tissue in the development of hepatocellular carcinoma, Invitrogen KRT19 antibody (Lab Vision Corporation, A53-B/A2.26) was used in immunohistochemistry on human samples (fig 1). BMC Res Notes (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen KRT19 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen KRT19 antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen KRT19 antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (AE-1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT19 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (AE1)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen KRT19 antibody (Zymed, AE1) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT19 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT19 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen KRT19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen KRT19 antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT19 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT19 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen KRT19 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen KRT19 antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-3)
  • immunohistochemistry; human; fig 5b
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, sc-376,126) was used in immunohistochemistry on human samples (fig 5b). J Exp Clin Cancer Res (2022) ncbi
mouse monoclonal (A-3)
  • western blot; mouse; 1:1000; loading ...; fig s2i
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, sc-376126) was used in western blot on mouse samples at 1:1000 (fig s2i). Nat Commun (2020) ncbi
mouse monoclonal (A-3)
  • immunohistochemistry; mouse; 1:300; loading ...
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, sc-376126) was used in immunohistochemistry on mouse samples at 1:300. Nature (2019) ncbi
mouse monoclonal (BA17)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 3c
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz Biotechnology, BA17) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 3c). J Vet Med Sci (2019) ncbi
mouse monoclonal (A-3)
  • immunohistochemistry - frozen section; rat; loading ...; fig s4a
Santa Cruz Biotechnology KRT19 antibody (SantaCruz, sc-376126) was used in immunohistochemistry - frozen section on rat samples (fig s4a). Oncotarget (2017) ncbi
mouse monoclonal (SPM266)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 2a
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, Sc-56371) was used in immunocytochemistry on mouse samples at 1:200 (fig 2a). Sci Rep (2017) ncbi
mouse monoclonal (A53-B/A2)
  • immunoprecipitation; human; loading ...; fig 3d
  • immunocytochemistry; human; loading ...; fig 2b
  • western blot; human; loading ...; fig s6
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, sc-6278) was used in immunoprecipitation on human samples (fig 3d), in immunocytochemistry on human samples (fig 2b) and in western blot on human samples (fig s6). Sci Rep (2016) ncbi
mouse monoclonal (RCK108)
  • western blot; human; 1:200; loading ...; fig 2d
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, sc-53003) was used in western blot on human samples at 1:200 (fig 2d). Oncotarget (2016) ncbi
mouse monoclonal (A-3)
  • immunohistochemistry; human; 1:500; fig 1c
Santa Cruz Biotechnology KRT19 antibody (SantaCruz, sc-376126) was used in immunohistochemistry on human samples at 1:500 (fig 1c). Cancer Sci (2016) ncbi
mouse monoclonal (BA17)
  • western blot; human; loading ...; fig 1b
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, SC-53258) was used in western blot on human samples (fig 1b). Oncogene (2017) ncbi
mouse monoclonal (A53-B/A2)
  • immunocytochemistry; human; 1:100; fig 3
In order to utilize the model system of primary human hepatocyte spheroids for drug-induced liver injury, disease, and liver function, Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, sc6278) was used in immunocytochemistry on human samples at 1:100 (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (SPM266)
  • western blot; rat; fig 2
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz, SC-56371) was used in western blot on rat samples (fig 2). Int J Mol Sci (2015) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry; human; 1:100
Santa Cruz Biotechnology KRT19 antibody (Santa Cruz Biotechnology, A53-B/A2) was used in immunohistochemistry on human samples at 1:100. Virchows Arch (2015) ncbi
Miltenyi Biotec
mouse monoclonal (CK3-6H5)
  • flow cytometry; human
Miltenyi Biotec KRT19 antibody (Miltenyi Biotec, 130-118-964) was used in flow cytometry on human samples . Front Immunol (2022) ncbi
Novus Biologicals
domestic rabbit polyclonal (OX-6)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2b
Novus Biologicals KRT19 antibody (Novus, NB100-687) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2b). Sci Adv (2021) ncbi
domestic rabbit polyclonal (OX-6)
  • immunocytochemistry; human; 1:100; loading ...; fig 2a
Novus Biologicals KRT19 antibody (Novus, NB100-687) was used in immunocytochemistry on human samples at 1:100 (fig 2a). Sci Rep (2020) ncbi
domestic rabbit polyclonal (OX-6)
In order to study the effect of bile acids on mesenchymal stem cells in liver, Novus Biologicals KRT19 antibody (Novus Biologicals, NB100-687) was used . Sci Rep (2015) ncbi
Dako
mouse monoclonal (RCK108)
  • immunohistochemistry; human; 1:100; loading ...; fig 1f
Dako KRT19 antibody (DAKO, M0888) was used in immunohistochemistry on human samples at 1:100 (fig 1f). J Clin Med (2019) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; human; fig 10d
Dako KRT19 antibody (Dako, M088) was used in immunohistochemistry on human samples (fig 10d). Development (2017) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; dogs; fig st7
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako KRT19 antibody (Dako, M0888) was used in immunohistochemistry - paraffin section on dogs samples (fig st7). J Toxicol Pathol (2017) ncbi
mouse monoclonal (RCK108)
  • immunocytochemistry; human; 1:200; loading ...; fig 7a
In order to report that hepatocytes rapidly upregulate NF- kB and Smad2/3 activity, and repress Notch signaling, Dako KRT19 antibody (Dako, M0888) was used in immunocytochemistry on human samples at 1:200 (fig 7a). Sci Rep (2017) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; mouse; 1:75; fig 4c
Dako KRT19 antibody (Dako, M0888) was used in immunohistochemistry - paraffin section on mouse samples at 1:75 (fig 4c). Oncotarget (2017) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; human; 1:100; loading ...; fig 5g
Dako KRT19 antibody (Dako, M0888) was used in immunohistochemistry on human samples at 1:100 (fig 5g). Nat Med (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; fig 2
Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (RCK108)
  • western blot; human; loading ...; fig 2a
Dako KRT19 antibody (Dako, RCK108) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; tbl 2
In order to measure galectin-3, cytokeratin-19, HBME-1, fibronectin, and cyclin D1 expression in cells of benign, malignant, and borderline tumors, Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry - paraffin section on human samples (tbl 2). Bull Exp Biol Med (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; fig 10
Dako KRT19 antibody (DakoCytomation, M0888) was used in immunohistochemistry - paraffin section on human samples (fig 10). J Orthop Res (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
In order to characterize and present the first case of fibroblastic reticular cell tumor of the breast, Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry - paraffin section on human samples at 1:50. Exp Ther Med (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 3b
Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3b). Histopathology (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; 1:200; fig 5
In order to assess the impact of thyroid dysregulation on the development of human embryonic stem cells-derived progenitor cells in vivo, Dako KRT19 antibody (Dako, M 0888) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5). Diabetes (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; human; 1:200; tbl 1
Dako KRT19 antibody (Dako, RCK 108) was used in immunohistochemistry on human samples at 1:200 (tbl 1). Oral Surg Oral Med Oral Pathol Oral Radiol (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; 1:40
In order to study markers of the epithelial to mesenchymal transition using invasive lobular carcinoma samples, Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry - paraffin section on human samples at 1:40. J Pathol (2016) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
Dako KRT19 antibody (Dako, RCK 108) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Diagn Pathol (2015) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4a
Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4a). Biomed Res Int (2015) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; mouse; 1:100
  • immunohistochemistry; human; 1:100
In order to show that biliary epithelial cells are not the primary source of CXLC12, Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry on mouse samples at 1:100 and in immunohistochemistry on human samples at 1:100. Am J Pathol (2015) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; human; 1:150
Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry on human samples at 1:150. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; human; 1:20
In order to describe the histological features canalicular adenoma, Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry on human samples at 1:20. Head Neck Pathol (2015) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry - frozen section; human; fig 6
In order to test if hepatocytes produce MMPs, regulated by CD147, that remodel fibrotic extracellular matrix independent of HSC, Dako KRT19 antibody (Dako Cytomation, RCK108) was used in immunohistochemistry - frozen section on human samples (fig 6). PLoS ONE (2014) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; human
Dako KRT19 antibody (Dako, RCK108) was used in immunohistochemistry on human samples . Hum Gene Ther Methods (2014) ncbi
mouse monoclonal (RCK108)
  • immunohistochemistry; human
In order to study the role of human eccrine sweat gland cells during epidermal regeneration, Dako KRT19 antibody (DAKO, RCK108) was used in immunohistochemistry on human samples . J Invest Dermatol (2014) ncbi
Cell Signaling Technology
mouse monoclonal (BA17)
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology KRT19 antibody (Cell Signaling, 4558) was used in western blot on human samples (fig 2a). Sci Rep (2016) ncbi
mouse monoclonal (BA17)
  • western blot; human; fig s1
In order to study the role of MAPK-microRNA in the interaction between cancer cells and neighboring fibroblasts, Cell Signaling Technology KRT19 antibody (Cell Signaling Tech, 4558S) was used in western blot on human samples (fig s1). Cancer Biol Ther (2015) ncbi
Developmental Studies Hybridoma Bank
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:10; loading ...; fig s9d
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:10 (fig s9d). Cell Rep Med (2022) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4b
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - frozen section on mouse samples (fig 4b). Cells (2022) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 2f
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III-c) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2f). Nat Commun (2022) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5b
Developmental Studies Hybridoma Bank KRT19 antibody (DHSB Iowa, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig 5b). Oncogene (2022) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 1b
  • immunocytochemistry; mouse; fig 2h
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1b) and in immunocytochemistry on mouse samples (fig 2h). J Cell Sci (2022) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 1j
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank (DSHB), TROMAIII) was used in immunohistochemistry on mouse samples (fig 1j). Cell Rep (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; human; loading ...; fig 4g
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMAIII) was used in immunohistochemistry on human samples (fig 4g). Commun Biol (2021) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; mouse; fig 7d
  • immunohistochemistry; mouse; 1:100; fig 6i
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunocytochemistry on mouse samples (fig 7d) and in immunohistochemistry on mouse samples at 1:100 (fig 6i). Cancer Res (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 1b
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry on mouse samples (fig 1b). Cancer Discov (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 5f
  • immunohistochemistry; human; loading ...; fig 5f
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, Troma III) was used in immunohistochemistry on mouse samples (fig 5f) and in immunohistochemistry on human samples (fig 5f). elife (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 1f
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1f). Int J Mol Sci (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s5
  • western blot; mouse; fig 4c
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, Troma III) was used in immunohistochemistry - paraffin section on mouse samples (fig s5) and in western blot on mouse samples (fig 4c). Mucosal Immunol (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 2b
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2b). elife (2021) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig s12b
  • immunocytochemistry; human; 1:100; loading ...; fig 1c
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA III) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig s12b) and in immunocytochemistry on human samples at 1:100 (fig 1c). Science (2021) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; mouse; 1:200; loading ...; fig s3d
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunocytochemistry on mouse samples at 1:200 (fig s3d). Development (2019) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1d
  • western blot; mouse; loading ...; fig 4c
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig 1d) and in western blot on mouse samples (fig 4c). Cell Death Differ (2019) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:3; loading ...; fig 5c
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:3 (fig 5c). Cell Death Dis (2018) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 3b
Developmental Studies Hybridoma Bank KRT19 antibody (DHSB, TROMA-III) was used in immunohistochemistry on mouse samples (fig 3b). Gastroenterology (2018) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 1d
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1d). Cancer Cell (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s2b
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig s2b). J Clin Invest (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1b
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, Troma-III) was used in immunohistochemistry - frozen section on mouse samples (fig 1b). J Exp Med (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; loading ...; fig 1d
In order to investigate the role of mitogen-activated protein kinase in pancreatitis, Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, Troma-III) was used in immunohistochemistry on mouse samples (fig 1d). Cell Mol Gastroenterol Hepatol (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 1d
In order to examine the expression and role of major facilitator super family domain containing 2a in liver regeneration, Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1d). Nat Commun (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; human; loading ...; fig 1b
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry on human samples (fig 1b). Oncotarget (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3d
In order to discuss the role of myeloid cells in pancreatic cancer pathogenesis, Developmental Studies Hybridoma Bank KRT19 antibody (hybridoma bank, TromaIII) was used in immunohistochemistry on mouse samples at 1:100 (fig 3d). Gut (2017) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - frozen section; mouse; fig 1
In order to analyze mediation of stellate and endothelial cell interactions during hepatic fibrosis due to murine junctional adhesion molecules JAM-B and JAM-C, Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - frozen section on mouse samples (fig 1). Cell Adh Migr (2016) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; mouse; 1:10; fig 4
In order to study a decrease in glutathione and SOX17 and toxin biliastresone that causes mouse extrahepatic cholangiocyte damage and fibrosis, Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMAIII) was used in immunocytochemistry on mouse samples at 1:10 (fig 4). Hepatology (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s2c
Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig s2c). Gastroenterology (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s2
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMAIII) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s2). Oncogene (2016) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; mouse; fig 2
In order to follow the presence of K14+ compound niches present in mouse cornea early after birth through expansion after debridement wounds, Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, Troma III) was used in immunocytochemistry on mouse samples (fig 2). Dev Dyn (2016) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; fig 4
  • immunohistochemistry - paraffin section; human; fig 4
In order to study hepatocellular carcinoma and ectopic lymphoid structures function as microniches for tumor progenitor cells, Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig 4) and in immunohistochemistry - paraffin section on human samples (fig 4). Nat Immunol (2015) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig s5e
In order to report that an inhibitor of the bromodomain and extraterminal family of proteins suppresses pancreatic ductal adenocarcinoma, Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TromaIII) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig s5e). Nat Med (2015) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; fig 1
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Genes Dev (2015) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; fig 2
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMAIII) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Oncotarget (2015) ncbi
rat monoclonal (TROMA-III)
  • immunocytochemistry; human; 1:20
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, Troma-III) was used in immunocytochemistry on human samples at 1:20. Front Cell Dev Biol (2015) ncbi
rat monoclonal (TROMA-III)
  • western blot; mouse; 1:500; fig s3
In order to research aggravation of murine caerulein-induced acute pancreatitis and the favoring of acinar keratin granule formation due to epiplakin deficiency, Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, Troma III) was used in western blot on mouse samples at 1:500 (fig s3). PLoS ONE (2014) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 2
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMA-III-c) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 2). Oncogene (2015) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; fig s2
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples (fig s2). Cell Death Differ (2014) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:400; fig 7
Developmental Studies Hybridoma Bank KRT19 antibody (Hydroma Bank, Troma III) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig 7). PLoS ONE (2014) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; rat; 1:750
Developmental Studies Hybridoma Bank KRT19 antibody (Hybridoma Bank, Troma-III) was used in immunohistochemistry - paraffin section on rat samples at 1:750. Alcohol Clin Exp Res (2014) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse
Developmental Studies Hybridoma Bank KRT19 antibody (Developmental Studies Hybridoma Bank, TROMA-III) was used in immunohistochemistry - paraffin section on mouse samples . Genes Dev (2013) ncbi
rat monoclonal (TROMA-III)
  • immunohistochemistry - paraffin section; mouse; 1:200
In order to study the roles of GATA4 and GATA6 in mouse pancreas organogenesis, Developmental Studies Hybridoma Bank KRT19 antibody (DSHB, TROMA III) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. J Clin Invest (2012) ncbi
MilliporeSigma
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2h
MilliporeSigma KRT19 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2h). J Clin Invest (2021) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; 1:200; loading ...; fig 7f, s4
  • immunohistochemistry; rat; 1:200; loading ...; fig 2d
MilliporeSigma KRT19 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry on human samples at 1:200 (fig 7f, s4) and in immunohistochemistry on rat samples at 1:200 (fig 2d). Nat Commun (2021) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Cancer Immunol Immunother (2020) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:50; fig 3a
MilliporeSigma KRT19 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry on mouse samples at 1:50 (fig 3a). Science (2018) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - frozen section; mouse; 1:500; fig s4a
In order to discover that myoepithelial cells born early during submucosal gland morphogenesis are multipotent progenitors with the capacity to differentiate into other glandular cell types, MilliporeSigma KRT19 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig s4a). Am J Respir Cell Mol Biol (2017) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to study the role of Tsc2 in normal and pathological kidney and lung functions, MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Am J Pathol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2a
In order to test if metastasis can be reduced by targeting cancer-associated fibroblasts with Pirfenidone, MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; loading ...; fig s5a
In order to study how tumor hypoxia affects DNA methylation, MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples (fig s5a). Nature (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; pigs ; 1:100; loading ...; fig 5h
In order to build and characterize a novel bioreactor platform, MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on pigs samples at 1:100 (fig 5h). Biotechnol J (2017) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:200
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry on mouse samples at 1:200. Nat Commun (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; loading ...; fig 2b
MilliporeSigma KRT19 antibody (Sigma, c2562) was used in immunohistochemistry on human samples (fig 2b). Nat Biotechnol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; human; 1:200; fig 5
MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunocytochemistry on human samples at 1:200 (fig 5). BMC Biol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; 1:4000; tbl 2
In order to measure the extent of squamous metaplasia in bronchial biopsies and correlate it to the presence of chronic obstructive pulmonary disease, MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry on human samples at 1:4000 (tbl 2). PLoS ONE (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse; fig 2
In order to characterize induction of lactation-specific tight junctions concurrent with beta-casein expression in mammary epithelial cells due to prolactin and glucocorticoid signaling, MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples (fig 2). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to study a model of immune functions of the mouse blood-cerebrospinal fluid barrier in vitro using primary epithelial cells better suited to study immune cell migration across the brain barrier, MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). Fluids Barriers CNS (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). Clin Cancer Res (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse
MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:800; fig 5
MilliporeSigma KRT19 antibody (Sigma, C2562) was used in immunohistochemistry on mouse samples at 1:800 (fig 5). Dis Model Mech (2015) ncbi
mouse monoclonal (A53-B/A2)
  • immunocytochemistry; human; 1:500; fig S6
MilliporeSigma KRT19 antibody (Sigma, A53-B/A2) was used in immunocytochemistry on human samples at 1:500 (fig S6). Cell Cycle (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to develop and validate a mouse model of endometriosis, MilliporeSigma KRT19 antibody (Sigma-Aldrich, #C2562) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Am J Pathol (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • western blot; rat
MilliporeSigma KRT19 antibody (Sigma, C2562) was used in western blot on rat samples . Carcinogenesis (2014) ncbi
mouse monoclonal (A53-B/A2)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:100
MilliporeSigma KRT19 antibody (Sigma-Aldrich, A53-B/A2) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:100. Biomaterials (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • western blot; pigs
  • western blot; human; 1:10,000
MilliporeSigma KRT19 antibody (Sigma-Aldrich, C 2562) was used in western blot on pigs samples and in western blot on human samples at 1:10,000. Mol Oncol (2014) ncbi
Leica Biosystems
monoclonal (b170)
  • immunohistochemistry - paraffin section; human; 1:25; fig 2
Leica Biosystems KRT19 antibody (Leica, b170) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 2). Hum Pathol (2017) ncbi
monoclonal (b170)
  • immunohistochemistry; dogs; fig S1d,S2d,S3d,S4d
In order to characterize an atypical cutaneous tumor of a 9-year-old mixed breed female dog, Leica Biosystems KRT19 antibody (Leica, b170) was used in immunohistochemistry on dogs samples (fig S1d,S2d,S3d,S4d). J Vet Med Sci (2017) ncbi
monoclonal (b170)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 4a
Leica Biosystems KRT19 antibody (Leica Biosystems, B170) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 4a). BMC Cancer (2016) ncbi
monoclonal (b170)
  • immunohistochemistry; rat; 1:200
Leica Biosystems KRT19 antibody (Novocastra Laboratories, b170) was used in immunohistochemistry on rat samples at 1:200. Exp Mol Pathol (2015) ncbi
monoclonal (b170)
  • immunohistochemistry - paraffin section; cat; 1:100; fig 2
Leica Biosystems KRT19 antibody (Novocastra, b170) was used in immunohistochemistry - paraffin section on cat samples at 1:100 (fig 2). Vet J (2014) ncbi
monoclonal (b170)
  • immunohistochemistry - paraffin section; human; 1:100
Leica Biosystems KRT19 antibody (Leica/Novocastra, b170) was used in immunohistochemistry - paraffin section on human samples at 1:100. Exp Hematol Oncol (2014) ncbi
Articles Reviewed
  1. Chen K, Zhang J, Huang Y, Tian X, Yang Y, Dong A. Single-cell RNA-seq transcriptomic landscape of human and mouse islets and pathological alterations of diabetes. iScience. 2022;25:105366 pubmed publisher
  2. Ravindranathan S, Passang T, Li J, Wang S, Dhamsania R, Ware M, et al. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nat Commun. 2022;13:6418 pubmed publisher
  3. Bahn M, Yu D, Lee M, Jo S, Lee J, Kim H, et al. Central role of Prominin-1 in lipid rafts during liver regeneration. Nat Commun. 2022;13:6219 pubmed publisher
  4. Hu S, Liu S, Bian Y, Poddar M, Singh S, Cao C, et al. Single-cell spatial transcriptomics reveals a dynamic control of metabolic zonation and liver regeneration by endothelial cell Wnt2 and Wnt9b. Cell Rep Med. 2022;3:100754 pubmed publisher
  5. Tu Q, Liu X, Yao X, Li R, Liu G, Jiang H, et al. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2022;41:274 pubmed publisher
  6. Yang L, Semmes E, Ovies C, Megli C, Permar S, Gilner J, et al. Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface. elife. 2022;11: pubmed publisher
  7. Merseburg A, Kasemir J, Buss E, Leroy F, Bock T, Porro A, et al. Seizures, behavioral deficits, and adverse drug responses in two new genetic mouse models of HCN1 epileptic encephalopathy. elife. 2022;11: pubmed publisher
  8. Yuan X, Duan X, Li Z, Yao B, Enhejirigala -, Song W, et al. Collagen triple helix repeat containing-1 promotes functional recovery of sweat glands by inducing adjacent microvascular network reconstruction in vivo. Burns Trauma. 2022;10:tkac035 pubmed publisher
  9. Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed publisher
  10. Mancinelli R, Ceci L, Kennedy L, Francis H, Meadows V, Chen L, et al. The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling. Cells. 2022;11: pubmed publisher
  11. Liu Y, Deguchi Y, Wei D, Liu F, Moussalli M, Deguchi E, et al. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ. Nat Commun. 2022;13:2665 pubmed publisher
  12. Kidger A, Saville M, Rushworth L, Davidson J, Stellzig J, Ono M, et al. Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6. Oncogene. 2022;41:2811-2823 pubmed publisher
  13. Pantasis S, Friemel J, Brütsch S, Hu Z, Krautbauer S, Liebisch G, et al. Vertebrate lonesome kinase modulates the hepatocyte secretome to prevent perivascular liver fibrosis and inflammation. J Cell Sci. 2022;135: pubmed publisher
  14. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed publisher
  15. Bruun J, Eide P, Bergsland C, Brück O, Svindland A, Arjama M, et al. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol. 2022;16:2312-2329 pubmed publisher
  16. Wu C, Cheng D, Peng Y, Li Y, Fu C, Wang Y, et al. Hepatic BRD4 Is Upregulated in Liver Fibrosis of Various Etiologies and Positively Correlated to Fibrotic Severity. Front Med (Lausanne). 2021;8:683506 pubmed publisher
  17. Molina L, Zhu J, Li Q, Pradhan Sundd T, Krutsenko Y, Sayed K, et al. Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitors. Cell Rep. 2021;36:109310 pubmed publisher
  18. Bailey K, Cartwright S, Patel N, Remmers N, Lazenby A, Hollingsworth M, et al. Porcine pancreatic ductal epithelial cells transformed with KRASG12D and SV40T are tumorigenic. Sci Rep. 2021;11:13436 pubmed publisher
  19. Pocaterra A, Scattolin G, Romani P, Ament C, Ribback S, Chen X, et al. Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development. Commun Biol. 2021;4:763 pubmed publisher
  20. Zhao Y, Li Z, Zhu Y, Fu J, Zhao X, Zhang Y, et al. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. Adv Sci (Weinh). 2021;8:e2003897 pubmed publisher
  21. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  22. Carter P, Schnell U, Chaney C, TONG B, Pan X, ye J, et al. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021;131: pubmed publisher
  23. Howell L, Jenkins R, Lynch S, Duckworth C, Kevin Park B, Goldring C. Proteomic profiling of murine biliary-derived hepatic organoids and their capacity for drug disposition, bioactivation and detoxification. Arch Toxicol. 2021;95:2413-2430 pubmed publisher
  24. Kemp S, Carpenter E, Steele N, Donahue K, Nwosu Z, Pacheco A, et al. Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB-Mediated Production of CXCL1. Cancer Res. 2021;81:4305-4318 pubmed publisher
  25. Flowers B, Xu H, Mulligan A, Hanson K, Seoane J, Vogel H, et al. Cell of Origin Influences Pancreatic Cancer Subtype. Cancer Discov. 2021;11:660-677 pubmed publisher
  26. Hendley A, Rao A, Leonhardt L, Ashe S, Smith J, Giacometti S, et al. Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree. elife. 2021;10: pubmed publisher
  27. Hsieh M, Weng C, Lin Y, Wu C, Chen L, Cheng K. Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice. Int J Mol Sci. 2021;22: pubmed publisher
  28. Huang L, Desai R, Conrad D, Leite N, Akshinthala D, Lim C, et al. Commitment and oncogene-induced plasticity of human stem cell-derived pancreatic acinar and ductal organoids. Cell Stem Cell. 2021;28:1090-1104.e6 pubmed publisher
  29. Hunter S, McIntosh B, Shi Y, Sperberg R, Funatogawa C, Labanieh L, et al. An engineered ligand trap inhibits leukemia inhibitory factor as pancreatic cancer treatment strategy. Commun Biol. 2021;4:452 pubmed publisher
  30. Hendricks Wenger A, Aycock K, Nagai Singer M, Coutermarsh Ott S, Lorenzo M, Gannon J, et al. Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Sci Rep. 2021;11:7584 pubmed publisher
  31. Krausová A, Buresova P, Sarnova L, Oyman Eyrilmez G, Skarda J, Wohl P, et al. Plectin ensures intestinal epithelial integrity and protects colon against colitis. Mucosal Immunol. 2021;14:691-702 pubmed publisher
  32. Hankeova S, Salplachta J, Zikmund T, Kavkova M, Van Hul N, Brinek A, et al. DUCT reveals architectural mechanisms contributing to bile duct recovery in a mouse model for Alagille syndrome. elife. 2021;10: pubmed publisher
  33. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed publisher
  34. Sampaziotis F, Muraro D, Tysoe O, Sawiak S, Beach T, Godfrey E, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science. 2021;371:839-846 pubmed publisher
  35. McGuire J, Frieling J, Lo C, Li T, Muhammad A, Lawrence H, et al. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nat Commun. 2021;12:723 pubmed publisher
  36. Hidalgo Sastre A, Kuebelsbeck L, Jochheim L, Staufer L, Altmayr F, Johannes W, et al. Toll-like receptor 3 expression in myeloid cells is essential for efficient regeneration after acute pancreatitis in mice. Eur J Immunol. 2021;51:1182-1194 pubmed publisher
  37. Alcedo K, Rouse M, Jung G, Fu D, Minor M, Willcockson H, et al. CD73 Maintains Hepatocyte Metabolic Integrity and Mouse Liver Homeostasis in a Sex-Dependent Manner. Cell Mol Gastroenterol Hepatol. 2021;12:141-157 pubmed publisher
  38. Chung W, Challagundla L, Zhou Y, Li M, Atfi A, Xu K. Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms. Life Sci Alliance. 2021;4: pubmed publisher
  39. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  40. Kasuga A, Semba T, Sato R, Nobusue H, Sugihara E, Takaishi H, et al. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice. Cancer Sci. 2021;112:1822-1838 pubmed publisher
  41. Sepe L, Hartl K, Iftekhar A, Berger H, Kumar N, Goosmann C, et al. Genotoxic Effect of Salmonella Paratyphi A Infection on Human Primary Gallbladder Cells. MBio. 2020;11: pubmed publisher
  42. Lau A, Li Z, Danai L, Westermark A, Darnell A, Ferreira R, et al. Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. elife. 2020;9: pubmed publisher
  43. Zhang J, Li Y, Liu Q, Huang Y, Li R, Wu T, et al. Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells. Hepatology. 2021;73:1140-1157 pubmed publisher
  44. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  45. Costanzo Garvey D, Keeley T, Case A, Watson G, Alsamraae M, Yu Y, et al. Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunol Immunother. 2020;69:1113-1130 pubmed publisher
  46. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  47. Cheung E, DeNicola G, Nixon C, Blyth K, Labuschagne C, Tuveson D, et al. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer. Cancer Cell. 2020;37:168-182.e4 pubmed publisher
  48. Rahman M, Wruck W, Spitzhorn L, Nguyen L, Bohndorf M, Martins S, et al. The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells. Sci Rep. 2020;10:739 pubmed publisher
  49. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  50. Shen J, Zhou Y, Zhang X, Peng W, Peng C, Zhou Q, et al. Loss of FoxA2 accelerates neoplastic changes in the intrahepatic bile duct partly via the MAPK signaling pathway. Aging (Albany NY). 2019;11:9280-9294 pubmed publisher
  51. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  52. Kim Y, You H, Park S, Kim M, Chae H, Park J, et al. A Mutation in ZNF143 as a Novel Candidate Gene for Endothelial Corneal Dystrophy. J Clin Med. 2019;8: pubmed publisher
  53. Segal J, Kent D, Wesche D, Ng S, Serra M, Oulès B, et al. Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors. Nat Commun. 2019;10:3350 pubmed publisher
  54. Mishra A, Emamgholi F, Erlangga Z, Hartleben B, Unger K, Wolff K, et al. Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing. Carcinogenesis. 2019;: pubmed publisher
  55. Zhou H, Wang L, Zhang C, Hu J, Chen J, Du W, et al. Feasibility of repairing full-thickness skin defects by iPSC-derived epithelial stem cells seeded on a human acellular amniotic membrane. Stem Cell Res Ther. 2019;10:155 pubmed publisher
  56. Prior N, Hindley C, Rost F, Meléndez E, Lau W, Gottgens B, et al. Lgr5+ stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool. Development. 2019;146: pubmed publisher
  57. Guiu J, Hannezo E, Yui S, Demharter S, Ulyanchenko S, Maimets M, et al. Tracing the origin of adult intestinal stem cells. Nature. 2019;570:107-111 pubmed publisher
  58. Krishna Subramanian S, Singer S, Armaka M, Banales J, Hölzer K, Schirmacher P, et al. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury. Cell Death Differ. 2019;: pubmed publisher
  59. Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L, et al. Reassessment of Exosome Composition. Cell. 2019;177:428-445.e18 pubmed publisher
  60. Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019;567:249-252 pubmed publisher
  61. Mona M, Miller R, Li H, Park Y, Zaman R, Yang L, et al. MIST1, an Inductive Signal for Salivary Amylase in Mesenchymal Stem Cells. Int J Mol Sci. 2019;20: pubmed publisher
  62. Liu M, O Connor R, Trefely S, Graham K, Snyder N, Beatty G. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal. Nat Immunol. 2019;20:265-275 pubmed publisher
  63. Lee S, Ji H, Baek S, Lee A, Kim M, Park S, et al. Feline-type cystic basal cell tumor filled with abundant melanin pigment-rich fluid in a dog. J Vet Med Sci. 2019;81:269-273 pubmed publisher
  64. Gorth D, Shapiro I, Risbud M. Transgenic mice overexpressing human TNF-α experience early onset spontaneous intervertebral disc herniation in the absence of overt degeneration. Cell Death Dis. 2018;10:7 pubmed publisher
  65. Wu T, Xu K, Martinek J, Young R, Banchereau R, George J, et al. IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer. Cancer Res. 2018;78:5243-5258 pubmed publisher
  66. Pommier A, Anaparthy N, Memos N, Kelley Z, Gouronnec A, Yan R, et al. Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases. Science. 2018;360: pubmed publisher
  67. Pereira E, Kedrin D, Seano G, Gautier O, Meijer E, Jones D, et al. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science. 2018;359:1403-1407 pubmed publisher
  68. He P, Yang J, Yang V, Bialkowska A. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice. Gastroenterology. 2018;154:1494-1508.e13 pubmed publisher
  69. Qin D, Yan Y, Hu B, Zhang W, Li H, Li X, et al. Wisp2 disruption represses Cxcr4 expression and inhibits BMSCs homing to injured liver. Oncotarget. 2017;8:98823-98836 pubmed publisher
  70. Brooks J, Fleischmann Mundt B, Woller N, Niemann J, Ribback S, Peters K, et al. Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer. Cancer Res. 2018;78:475-488 pubmed publisher
  71. Mello S, Valente L, Raj N, Seoane J, Flowers B, McClendon J, et al. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. Cancer Cell. 2017;32:460-473.e6 pubmed publisher
  72. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  73. Van T, Polykratis A, Straub B, Kondylis V, Papadopoulou N, Pasparakis M. Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis. J Clin Invest. 2017;127:2662-2677 pubmed publisher
  74. Kamerkar S, LeBleu V, Sugimoto H, Yang S, Ruivo C, Melo S, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546:498-503 pubmed publisher
  75. Haston S, Pozzi S, Carreno G, Manshaei S, Panousopoulos L, González Meljem J, et al. MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma. Development. 2017;144:2141-2152 pubmed publisher
  76. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  77. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  78. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  79. Braxton D, Saxe D, Damjanov N, Stashek K, Shroff S, Morrissette J, et al. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma". Hum Pathol. 2017;62:232-241 pubmed publisher
  80. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  81. Delhove J, Buckley S, Perocheau D, Karda R, Arbuthnot P, Henderson N, et al. Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in mice. Sci Rep. 2017;7:41874 pubmed publisher
  82. Watanabe K, Chambers J, Uchida K, Nibe K, Ushio N, Horiuchi N, et al. A cutaneous mixed tumor in a dog. J Vet Med Sci. 2017;79:670-673 pubmed publisher
  83. Anderson P, Lynch T, Engelhardt J. Multipotent Myoepithelial Progenitor Cells Are Born Early during Airway Submucosal Gland Development. Am J Respir Cell Mol Biol. 2017;56:716-726 pubmed publisher
  84. Abboud Jarrous G, Priya S, Maimon A, Fischman S, Cohen Elisha M, Czerninski R, et al. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL. Oncotarget. 2017;8:13986-14002 pubmed publisher
  85. Yamaguchi T, Sato H, Kato Itoh M, Goto T, Hara H, Sanbo M, et al. Interspecies organogenesis generates autologous functional islets. Nature. 2017;542:191-196 pubmed publisher
  86. Poon M, Jiang D, Qin P, Zhang Y, Qiu B, Chanda S, et al. Inhibition of NUCKS Facilitates Corneal Recovery Following Alkali Burn. Sci Rep. 2017;7:41224 pubmed publisher
  87. Roy I, Boyle K, Vonderhaar E, Zimmerman N, Gorse E, Mackinnon A, et al. Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Lab Invest. 2017;97:302-317 pubmed publisher
  88. Halbrook C, Wen H, Ruggeri J, Takeuchi K, Zhang Y, di Magliano M, et al. Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis. Cell Mol Gastroenterol Hepatol. 2017;3:99-118 pubmed publisher
  89. Hopkinson B, Klitgaard M, Petersen O, Villadsen R, Rønnov Jessen L, Kim J. Establishment of a normal-derived estrogen receptor-positive cell line comparable to the prevailing human breast cancer subtype. Oncotarget. 2017;8:10580-10593 pubmed publisher
  90. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  91. Sørensen K, Meldgaard T, Melchjorsen C, Fridriksdottir A, Pedersen H, Petersen O, et al. Upregulation of Mrps18a in breast cancer identified by selecting phage antibody libraries on breast tissue sections. BMC Cancer. 2017;17:19 pubmed publisher
  92. Ohtsuka T, Sakaguchi M, Yamamoto H, Tomida S, Takata K, Shien K, et al. Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway. Sci Rep. 2016;6:39557 pubmed publisher
  93. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  94. Erdogan Durmus S, Ozcan D, Yarikkaya E, Kurt A, Arslan A. CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions. J Res Med Sci. 2016;21:49 pubmed
  95. Takano M, Shimada K, Fujii T, Morita K, Takeda M, Nakajima Y, et al. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis. BMC Cancer. 2016;16:903 pubmed
  96. Pu W, Zhang H, Huang X, Tian X, He L, Wang Y, et al. Mfsd2a+ hepatocytes repopulate the liver during injury and regeneration. Nat Commun. 2016;7:13369 pubmed publisher
  97. Li Q, Wang H, Zogopoulos G, Shao Q, Dong K, Lv F, et al. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7:77838-77853 pubmed publisher
  98. Ren S, Luo Y, Chen H, Warburton D, Lam H, Wang L, et al. Inactivation of Tsc2 in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization. Am J Pathol. 2016;186:3261-3272 pubmed publisher
  99. Takai K, Le A, Weaver V, Werb Z. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget. 2016;7:82889-82901 pubmed publisher
  100. Frentzas S, Simoneau E, Bridgeman V, Vermeulen P, Foo S, Kostaras E, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016;22:1294-1302 pubmed publisher
  101. Lamballe F, Toscano S, Conti F, Arechederra M, Baeza N, Figarella Branger D, et al. Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells. Oncotarget. 2016;7:74747-74767 pubmed publisher
  102. Kuga T, Kume H, Adachi J, Kawasaki N, Shimizu M, Hoshino I, et al. Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON. Sci Rep. 2016;6:34472 pubmed publisher
  103. Suzuki Y, Katagiri H, Wang T, Kakisaka K, Kume K, Nishizuka S, et al. Ductular reactions in the liver regeneration process with local inflammation after physical partial hepatectomy. Lab Invest. 2016;96:1211-1222 pubmed publisher
  104. Muzumdar M, Dorans K, Chung K, Robbins R, Tammela T, Gocheva V, et al. Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers. Nat Commun. 2016;7:12685 pubmed publisher
  105. Thienpont B, Steinbacher J, Zhao H, D Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537:63-68 pubmed publisher
  106. Schuerlein S, Schwarz T, Krziminski S, Gätzner S, Hoppensack A, Schwedhelm I, et al. A versatile modular bioreactor platform for Tissue Engineering. Biotechnol J. 2017;12: pubmed publisher
  107. Yoshida M, Miyasaka Y, Ohuchida K, Okumura T, Zheng B, Torata N, et al. Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model. Cancer Sci. 2016;107:1443-1452 pubmed publisher
  108. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  109. Zhang Y, Velez Delgado A, Mathew E, Li D, Mendez F, Flannagan K, et al. Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer. Gut. 2017;66:124-136 pubmed publisher
  110. Chen H, Wei Z, Sun J, Bhattacharya A, Savage D, Serda R, et al. A recellularized human colon model identifies cancer driver genes. Nat Biotechnol. 2016;34:845-51 pubmed publisher
  111. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  112. Saha S, Choi H, Kim B, Dayem A, Yang G, Kim K, et al. KRT19 directly interacts with β-catenin/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties. Oncogene. 2017;36:332-349 pubmed publisher
  113. Li H, Mai R, Huang H, Chou C, Chang Y, Chang Y, et al. DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma. Sci Rep. 2016;6:28637 pubmed publisher
  114. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  115. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  116. Rigden H, Alias A, Havelock T, O Donnell R, Djukanovic R, Davies D, et al. Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016;11:e0156009 pubmed publisher
  117. Hamam D, Abdouh M, Gao Z, Arena V, Arena M, Arena G. Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients. J Exp Clin Cancer Res. 2016;35:80 pubmed publisher
  118. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  119. Giovannini C, Minguzzi M, Genovese F, Baglioni M, Gualandi A, Ravaioli M, et al. Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma. Oncotarget. 2016;7:39609-39626 pubmed publisher
  120. Cetin S, Kir G, Yilmaz M. Thyroid Paraganglioma Diagnosed by Fine-Needle Aspiration Biopsy, Correlated With Histopathological Findings: Report of a Case. Diagn Cytopathol. 2016;44:643-7 pubmed publisher
  121. Bell C, Hendriks D, Moro S, Ellis E, Walsh J, Renblom A, et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep. 2016;6:25187 pubmed publisher
  122. Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed publisher
  123. Hintermann E, Bayer M, Ehser J, Aurrand Lions M, Pfeilschifter J, Imhof B, et al. Murine junctional adhesion molecules JAM-B and JAM-C mediate endothelial and stellate cell interactions during hepatic fibrosis. Cell Adh Migr. 2016;10:419-33 pubmed publisher
  124. Waisbourd Zinman O, Koh H, Tsai S, Lavrut P, Dang C, Zhao X, et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology. 2016;64:880-93 pubmed publisher
  125. Abrosimov A, Dvinskikh N, Sidorin A. Cells of Benign and Borderline Thyroid Tumor Express Malignancy Markers. Bull Exp Biol Med. 2016;160:698-701 pubmed publisher
  126. Hong X, Zhang J, Wu Q, Wang W, Ye A, Song W, et al. Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice. Oncotarget. 2016;7:22700-10 pubmed publisher
  127. Yang S, Sun Y, Geng Z, Ma K, Sun X, Fu X. Abnormalities in the basement membrane structure promote basal keratinocytes in the epidermis of hypertrophic scars to adopt a proliferative phenotype. Int J Mol Med. 2016;37:1263-73 pubmed publisher
  128. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  129. Song G, Pacher M, Balakrishnan A, Yuan Q, Tsay H, Yang D, et al. Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis. Cell Stem Cell. 2016;18:797-808 pubmed publisher
  130. Rodrigues Pinto R, Berry A, Piper Hanley K, Hanley N, Richardson S, Hoyland J. Spatiotemporal analysis of putative notochordal cell markers reveals CD24 and keratins 8, 18, and 19 as notochord-specific markers during early human intervertebral disc development. J Orthop Res. 2016;34:1327-40 pubmed publisher
  131. Li H, Shen P, Liang Y, Zhang F. Fibroblastic reticular cell tumor of the breast: A case report and review of the literature. Exp Ther Med. 2016;11:561-564 pubmed
  132. Lazarevic I, Engelhardt B. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier. Fluids Barriers CNS. 2016;13:2 pubmed publisher
  133. Guedj N, Vaquero J, Clapéron A, Mergey M, Chrétien Y, Paradis V, et al. Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin. Histopathology. 2016;69:211-21 pubmed publisher
  134. Bruin J, Saber N, O Dwyer S, Fox J, Mojibian M, Arora P, et al. Hypothyroidism Impairs Human Stem Cell-Derived Pancreatic Progenitor Cell Maturation in Mice. Diabetes. 2016;65:1297-309 pubmed publisher
  135. Martínez Martínez M, Mosqueda Taylor A, Delgado Azañero W, Rumayor Piña A, de Almeida O. Primary intraosseous squamous cell carcinoma arising in an odontogenic keratocyst previously treated with marsupialization: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e87-95 pubmed publisher
  136. Fleury H, Communal L, Carmona E, Portelance L, Arcand S, Rahimi K, et al. Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes Cancer. 2015;6:378-398 pubmed
  137. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  138. Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke J, et al. Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells. Oncogene. 2016;35:3880-6 pubmed publisher
  139. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  140. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  141. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  142. Korytnikov R, Nostro M. Generation of polyhormonal and multipotent pancreatic progenitor lineages from human pluripotent stem cells. Methods. 2016;101:56-64 pubmed publisher
  143. Pajoohesh Ganji A, Pal Ghosh S, Tadvalkar G, Stepp M. K14 + compound niches are present on the mouse cornea early after birth and expand after debridement wounds. Dev Dyn. 2016;245:132-43 pubmed publisher
  144. McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher
  145. Dunđerović D, Lipkovski J, Boričic I, Soldatović I, Božic V, Cvejić D, et al. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature. Diagn Pathol. 2015;10:196 pubmed publisher
  146. Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16:1235-44 pubmed publisher
  147. Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med. 2015;21:1364-71 pubmed publisher
  148. Hurley P, Sundi D, Shinder B, Simons B, Hughes R, Miller R, et al. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res. 2016;22:448-58 pubmed publisher
  149. Mazur P, Herner A, Mello S, Wirth M, Hausmann S, Sánchez Rivera F, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med. 2015;21:1163-71 pubmed publisher
  150. Sawitza I, Kordes C, Götze S, Herebian D, Häussinger D. Bile acids induce hepatic differentiation of mesenchymal stem cells. Sci Rep. 2015;5:13320 pubmed publisher
  151. He D, Lu Y, Hu H, Zhang J, Qin B, Wang Y, et al. The Wnt11 Signaling Pathway in Potential Cellular EMT and Osteochondral Differentiation Progression in Nephrolithiasis Formation. Int J Mol Sci. 2015;16:16313-29 pubmed publisher
  152. Shah S, Miller P, Garcia Contreras M, Ao Z, Machlin L, Issa E, et al. Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype. Cancer Biol Ther. 2015;16:1671-81 pubmed publisher
  153. Labouba I, Le Page C, Communal L, Kristessen T, You X, Péant B, et al. Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay. PLoS ONE. 2015;10:e0131024 pubmed publisher
  154. Chiou S, Winters I, Wang J, Naranjo S, Dudgeon C, Tamburini F, et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes Dev. 2015;29:1576-85 pubmed publisher
  155. Malik I, Stange I, Martius G, Cameron S, Rave Fränk M, Hess C, et al. Role of PECAM-1 in radiation-induced liver inflammation. J Cell Mol Med. 2015;19:2441-52 pubmed publisher
  156. Krah N, De La O J, Swift G, Hoang C, Willet S, Chen Pan F, et al. The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. elife. 2015;4: pubmed publisher
  157. Trimboli P, Guidobaldi L, Amendola S, Nasrollah N, Romanelli F, Attanasio D, et al. Galectin-3 and HBME-1 improve the accuracy of core biopsy in indeterminate thyroid nodules. Endocrine. 2016;52:39-45 pubmed publisher
  158. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  159. Penheiter A, Erdogan S, Murphy S, Hart S, Felipe Lima J, Rakhshan Rohakhtar F, et al. Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma. Biomed Res Int. 2015;2015:593572 pubmed publisher
  160. Kwon J, NABINGER S, Vega Z, Sahu S, Alluri R, Abdul Sater Z, et al. Pathophysiological role of microRNA-29 in pancreatic cancer stroma. Sci Rep. 2015;5:11450 pubmed publisher
  161. Yuri S, Nishikawa M, Yanagawa N, Jo O, Yanagawa N. Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor. PLoS ONE. 2015;10:e0129242 pubmed publisher
  162. Huo C, Chew G, Hill P, Huang D, Ingman W, Hodson L, et al. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium. Breast Cancer Res. 2015;17:79 pubmed publisher
  163. Berry R, Ozdemir D, Aronow B, Lindström N, Dudnakova T, Thornburn A, et al. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice. Dis Model Mech. 2015;8:903-17 pubmed publisher
  164. Fatourou E, Koskinas J, Karandrea D, Palaiologou M, Syminelaki T, Karanikolas M, et al. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2015;27:1094-102 pubmed publisher
  165. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  166. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  167. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  168. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  169. Saiman Y, Sugiyama T, Simchoni N, Spirli C, Bansal M. Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12. Am J Pathol. 2015;185:1859-66 pubmed publisher
  170. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  171. Hines W, Yaswen P, Bissell M. Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias. Nat Commun. 2015;6:6927 pubmed publisher
  172. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  173. Li X, Tao J, Cigliano A, Sini M, Calderaro J, Azoulay D, et al. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102-15 pubmed
  174. Lee J, Garbe J, Vrba L, Miyano M, Futscher B, Stampfer M, et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol. 2015;3:13 pubmed publisher
  175. Yassin F. Diagnostic criteria of well differentiated thyroid tumor of uncertain malignant potential; a histomorphological and immunohistochemical appraisal. J Egypt Natl Canc Inst. 2015;27:59-67 pubmed publisher
  176. Bogaerts E, Heindryckx F, Devisscher L, Paridaens A, Vandewynckel Y, Van den Bussche A, et al. Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors. PLoS ONE. 2015;10:e0119555 pubmed publisher
  177. Tennakoon A, Izawa T, Wijesundera K, Katou Ichikawa C, Tanaka M, Golbar H, et al. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Mol Pathol. 2015;98:476-85 pubmed publisher
  178. Chen Q, Gu Y, Liu B. Clinicopathological characteristics of kidney mucinous tubular and spindle cell carcinoma. Int J Clin Exp Pathol. 2015;8:1007-12 pubmed
  179. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  180. Yui T, Ohmachi T, Matsuda K, Okamoto M, Taniyama H. Histochemical and immunohistochemical characterization of chordoma in ferrets. J Vet Med Sci. 2015;77:467-73 pubmed publisher
  181. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  182. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  183. BaÅŸak K, KiroÄŸlu K. Multiple oncocytic cystadenoma with intraluminal crystalloids in parotid gland: case report. Medicine (Baltimore). 2014;93:e246 pubmed publisher
  184. Garbe J, Vrba L, Sputova K, Fuchs L, Novak P, Brothman A, et al. Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. Cell Cycle. 2014;13:3423-35 pubmed publisher
  185. van Sprundel R, van den Ingh T, Guscetti F, Kershaw O, van Wolferen M, Rothuizen J, et al. Classification of primary hepatic tumours in the cat. Vet J. 2014;202:255-66 pubmed publisher
  186. Calangiu C, Simionescu C, Stepan A, Cernea D, Zăvoi R, Mărgăritescu C. The expression of CK19, vimentin and E-cadherin in differentiated thyroid carcinomas. Rom J Morphol Embryol. 2014;55:919-25 pubmed
  187. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  188. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  189. Wögenstein K, Szabo S, Lunova M, Wiche G, Haybaeck J, Strnad P, et al. Epiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granules. PLoS ONE. 2014;9:e108323 pubmed publisher
  190. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  191. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  192. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  193. Morris S, Carter K, Baek J, Koszarek A, Yeh M, Knoblaugh S, et al. TGF-? signaling alters the pattern of liver tumorigenesis induced by Pten inactivation. Oncogene. 2015;34:3273-82 pubmed publisher
  194. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  195. Calabro S, Maczurek A, Morgan A, Tu T, Wen V, Yee C, et al. Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis. PLoS ONE. 2014;9:e90571 pubmed publisher
  196. Ouyang H, Xue Y, Lin Y, Zhang X, Xi L, Patel S, et al. WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis. Nature. 2014;511:358-61 pubmed publisher
  197. Ehlken H, Krishna Subramanian S, Ochoa Callejero L, Kondylis V, Nadi N, Straub B, et al. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout. Cell Death Differ. 2014;21:1721-32 pubmed publisher
  198. Greaves E, Cousins F, Murray A, Esnal Zufiaurre A, Fassbender A, Horne A, et al. A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometrium. Am J Pathol. 2014;184:1930-9 pubmed publisher
  199. Zhang L, Frank R, Furth E, Ziober A, LiVolsi V, Zhang P. Expression and diagnostic values of calretinin and CK5/6 in cholangiocarcinoma. Exp Hematol Oncol. 2014;3:12 pubmed publisher
  200. Shimoda M, Chen S, Noguchi H, Takita M, Sugimoto K, Itoh T, et al. A new method for generating insulin-secreting cells from human pancreatic epithelial cells after islet isolation transformed by NeuroD1. Hum Gene Ther Methods. 2014;25:206-19 pubmed publisher
  201. Balk Møller E, Kim J, Hopkinson B, Timmermans Wielenga V, Petersen O, Villadsen R. A marker of endocrine receptor-positive cells, CEACAM6, is shared by two major classes of breast cancer: luminal and HER2-enriched. Am J Pathol. 2014;184:1198-208 pubmed publisher
  202. Ryszawy D, Sarna M, Rak M, Szpak K, Kedracka Krok S, Michalik M, et al. Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer. Carcinogenesis. 2014;35:1920-30 pubmed publisher
  203. Ye J, Vives Pi M, Gillespie K. Maternal microchimerism: increased in the insulin positive compartment of type 1 diabetes pancreas but not in infiltrating immune cells or replicating islet cells. PLoS ONE. 2014;9:e86985 pubmed publisher
  204. Pontiggia L, Biedermann T, Böttcher Haberzeth S, Oliveira C, Braziulis E, Klar A, et al. De novo epidermal regeneration using human eccrine sweat gland cells: higher competence of secretory over absorptive cells. J Invest Dermatol. 2014;134:1735-1742 pubmed publisher
  205. Liu Z, Yu N, Holz F, Yang F, Stanzel B. Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials. 2014;35:2837-50 pubmed publisher
  206. Karaca G, Swiderska Syn M, Xie G, Syn W, Krüger L, Machado M, et al. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice. PLoS ONE. 2014;9:e83987 pubmed publisher
  207. Stratmann A, Fecher D, Wangorsch G, Göttlich C, Walles T, Walles H, et al. Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model. Mol Oncol. 2014;8:351-65 pubmed publisher
  208. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  209. Chan I, Guy C, Machado M, Wank A, Kadiyala V, Michelotti G, et al. Alcohol activates the hedgehog pathway and induces related procarcinogenic processes in the alcohol-preferring rat model of hepatocarcinogenesis. Alcohol Clin Exp Res. 2014;38:787-800 pubmed publisher
  210. Liu H, Zhang W, Jia Y, Yu Q, Grau G, Peng L, et al. Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells. Cell Death Dis. 2013;4:e857 pubmed publisher
  211. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  212. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  213. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  214. Rodrigues R, De Kock J, Branson S, Vinken M, Meganathan K, Chaudhari U, et al. Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals. Stem Cells Dev. 2014;23:44-55 pubmed publisher
  215. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  216. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  217. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  218. Sigurdsson V, Ingthorsson S, Hilmarsdottir B, Gustafsdottir S, Franzdóttir S, Arason A, et al. Expression and functional role of sprouty-2 in breast morphogenesis. PLoS ONE. 2013;8:e60798 pubmed publisher
  219. Moffatt Jauregui C, Robinson B, de Moya A, Brockman R, Roman A, Cash M, et al. Establishment and characterization of a telomerase immortalized human gingival epithelial cell line. J Periodontal Res. 2013;48:713-21 pubmed publisher
  220. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  221. Reichert M, Takano S, von Burstin J, Kim S, Lee J, Ihida Stansbury K, et al. The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes Dev. 2013;27:288-300 pubmed publisher
  222. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  223. Takahashi Y, Kupferman M, Bell D, Jiffar T, Lee J, Xie T, et al. Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012;18:6178-87 pubmed publisher
  224. Carrasco M, Delgado I, Soria B, Martin F, Rojas A. GATA4 and GATA6 control mouse pancreas organogenesis. J Clin Invest. 2012;122:3504-15 pubmed publisher
  225. Guimei M, Baddour N, Elkaffash D, Abdou L, Taher Y. Gremlin in the pathogenesis of hepatocellular carcinoma complicating chronic hepatitis C: an immunohistochemical and PCR study of human liver biopsies. BMC Res Notes. 2012;5:390 pubmed publisher
  226. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  227. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  228. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  229. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  230. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  231. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  232. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  233. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  234. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  235. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed